Potential Role of Curcumin for the Treatment of Major Depressive Disorder

被引:0
|
作者
Adrian L. Lopresti
机构
[1] Clinical Research Australia,College of Science, Health, Engineering and Education
[2] Murdoch University,undefined
来源
CNS Drugs | 2022年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Curcumin is the major biologically active polyphenolic constituent in the turmeric plant (Curcuma longa) that has been shown to have antioxidant, anti-inflammatory, neuroprotective, anticancer, antimicrobial, and cardioprotective effects. Interest in curcumin as a treatment for mental health conditions has increased and there is an expanding body of preclinical and clinical research examining its antidepressant and anxiolytic effects. In this narrative review, human trials investigating the effects of curcumin for the treatment of depression or depressive symptoms are summarised. Using findings from in vitro, animal, and human trials, possible biological mechanisms associated with the antidepressant effects of curcumin are also explored. To increase the understanding of curcumin for the treatment of depression, directions for future research are proposed.
引用
收藏
页码:123 / 141
页数:18
相关论文
共 50 条
  • [31] Treatment guidelines for major depressive disorder
    Hollon, SD
    Shelton, RC
    BEHAVIOR THERAPY, 2001, 32 (02) : 235 - 258
  • [32] Amantadine: a treatment for major depressive disorder
    Ruiz-Chow, A.
    Ramirez-Bermudez, J.
    Alviso-de la Serna, L.
    Rios, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S352 - S352
  • [33] Vortioxetine for the treatment of major depressive disorder
    Tritschler, Laurent
    Felice, Daniela
    Colle, Romain
    Guilloux, Jean-Philippe
    Corruble, Emmanuelle
    Gardier, Alain Michel
    David, Denis Joseph
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (06) : 731 - 745
  • [34] Agomelatine Treatment of Major Depressive Disorder
    Dolder, Christian R.
    Nelson, Michael
    Snider, Morgan
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (12) : 1822 - 1831
  • [35] Desvenlafaxine in the treatment of major depressive disorder
    Lourenco, Maria Teresa C.
    Kennedy, Sidney H.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 127 - 136
  • [36] Desvenlafaxine for the treatment of major depressive disorder
    Kornstein, Susan G.
    McIntyre, Roger S.
    Thase, Michael E.
    Boucher, Matthieu
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (10) : 1449 - 1463
  • [37] Vortioxetine in the treatment of major depressive disorder
    Baldwin, David S.
    Hanumanthaiah, Venkatesh Ballagere
    FUTURE NEUROLOGY, 2015, 10 (02) : 79 - 89
  • [38] Vilazodone for the Treatment of Major Depressive Disorder
    Iranikhah, Maryam
    Wensel, Terri M.
    Thomason, Angela R.
    PHARMACOTHERAPY, 2012, 32 (10): : 958 - 965
  • [39] Diagnosis and Treatment of Major Depressive Disorder
    Soleimani, Laili
    Lapidus, Kyle A. B.
    Iosifescu, Dan V.
    NEUROLOGIC CLINICS, 2011, 29 (01) : 177 - +
  • [40] Treatment of major depressive disorder in epilepsy
    Radmanovic, B.
    Dejanovic, S. Djukic
    Ravanic, D.
    Mihajlovic, G.
    Pantovic, M.
    Janjic, V.
    Jovanovic, M.
    Radmanovic, O.
    Ilic, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 154 - 154